Pharmaceutical Industry Information Portal

HomeNews

News

Hikma Pharmaceuticals down 30%, stock to buy on fall

Hikma Pharmaceuticals is one of the biggest UK biotech stocks, only trailing giants like AstraZeneca and GlaxoSmithKline. Hikma was founded in 1978. Over the...

FDA approves Lilly and Incyte’s Olumiant® for alopecia areata

Eli Lilly and Company and Incyte announced  that the U.S. Food and Drug Administration (FDA) has approved OLUMIANT® (baricitinib), a once-daily pill, as a...

Cogent Biosciences begins $125 million public offering

Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that it has commenced an underwritten public...

BioNTech begins construction of mRNA vaccine plant in Rwanda soon

COVID-19 vaccine maker BioNTech said construction of an mRNA vaccine factory to enable African nations to jump-start their own manufacturing network would start on...

GSK comes close to creating a hard-to-reach RSV vaccine

GSK aims to get its respiratory syncytial virus (RSV) vaccine to regulators for review later this year, after interim data showed the vaccine was...

Bluejay Diagnostics shares down 31% after rising Thursday

Bluejay Diagnostics Inc. shares reversed course from Thursday's gains, dropping 31% to $1.12 one day after saying the Food and Drug Administration has agreed...
spot_img

Expert Articles

spot_img